Abstract: This article analyzes the research problem of price-setting strategies for product innovations in the MedTech industry. It is based on the conceptual framework of price-setting practices, strategies, and models. A multiple case study research is then performed on six medical technology companies, focusing on how they set their initial product price for a new technology solution to either existing medical conditions or technology limitations. The research results show that MedTech companies opt for competition-informed price practices and buy pricing models. The pricing strategies vary between skimming and market-based pricing strategies. Price innovations are limited due to regulation and financial considerations.

Read more in the November 2017 issue of the ISM Journal of International Business (Pages 27-34).

More articles

Strategic Shifts: The Science of Transient Competitive Advantage

by Danish Jamal Khan, ISM DBA Student
The Changing Landscape of Organizations

Today’s organizations are vastly different from those operating in the pre-digital era. The…

Read More

Strategy 3.0 in the 3.0 World

by Danish Jamal Khan, ISM DBA Student
The Technological Revolution

The technological revolution has transformed our world over the past few decades. Nearly every aspect…

Read More

The Silent Struggle: Mental Health as the Invisible Dimension of Diversity

by Tabea Dahn

It is widely said that “diversity is about more than race.” But people often think about social class, generational differences,…

Read More

Our Accreditation

  • ATHEA Accreditation

Our Recognition

  • US State Authority to
    Confer Diplomas
  • Status with the French
    Ministry of Education
  • Établissement d'enseignement
    supérieur privé technique

Our Membership